CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Understanding the mechanism of chemoresistance and disease progression in patients with prostate cancer is important for developing novel treatment strategies. In particular, developing resistance to cabazitaxel is a major challenge in patients with docetaxel‐resistant and castration‐resistant prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsagdorj, Ariunbold, Izumi, Kouji, Hiratsuka, Kaoru, Machioka, Kazuaki, Iwamoto, Hiroaki, Naito, Renato, Makino, Tomoyuki, Kadomoto, Suguru, Shigehara, Kazuyoshi, Kadono, Yoshifumi, Lin, Wen‐Jye, Maolake, Aerken, Mizokami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317938/
https://www.ncbi.nlm.nih.gov/pubmed/30426599
http://dx.doi.org/10.1111/cas.13876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317938/
https://www.ncbi.nlm.nih.gov/pubmed/30426599
http://dx.doi.org/10.1111/cas.13876

Ejemplares similares